• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Identification and validation of novel virulence factors of Helicobacter pylori

Research Project

Project/Area Number 12670459
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionTHE UNIVERSITY OF TOKYO

Principal Investigator

YOSHIDA Haruhiko  HOSPITAL, The University of Tokyo, ASSISTANT, 医学部・附属病院, 助手 (60240305)

Co-Investigator(Kenkyū-buntansha) OGURA Keiji  HOSPITAL, The University of Tokyo, FELLOW, 医学部・附属病院, 医員
SHIRATORI Yasushi  HOSPITAL, The University of Tokyo, LECTURER, 医学部・附属病院, 講師 (70196624)
Project Period (FY) 2000 – 2001
KeywordsHelicobacter pylori / CagA / cagPAI / Mongolian gerbil / intracellular signaling pathways / virulence
Research Abstract

First, we sought to confirm previously reported virulence factors, especially cagPAI. We compared anti-CagA antibody seropositivity between gastric cancer patients and matched controls by using recombinant CagA (a product of cagPAI) and found that anti-CagA positivity was associated with an odds ratio of 10 concerning gastric cancer. We also validated virulence of cagPAI in Mongolian gerbils using cagPAI gene knocked out mutants, showing that inflammation and tumorogenesis require cagPAI.
Next, we investigated H. pylori-mediated induction of intracellular signaling pathways and demonstrated activation of NF-kappa B through IKK and TRAFs ; of SRE and AP-1 through the ERK cascade ; and of cyclin D1 through the MAPK cascade. The presence of cagPAI and direct contact between bacteria and host cells were required in the induction of those intracellular signals. We applied cDNA microarray analysis to examine various gene expressions in the host cells.
Finally, we established a short-term Mongolian gerbil infection model to validate H. pylori virulence factors in vivo.

  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Maeda S, et al.: "Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used"Cancer. 88. 1530-1535 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maeda S, et al.: "H. pylori activates NF-kappa B through a signaling pathway involving I kappa B kinases, NF-kappa B inducing kinase, TRAF2, and TRAF6 in gastric cancer cells"Gastroenterology. 119. 97-108 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogura K, et al.: "Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbils"Journal of Experimental Medicine. 192. 1601-1610 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mitsuno Y, et al.: "Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signaling pathway in gastric cancer cells"Gut. 49. 18-22 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maeda S, et al.: "cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells"Biochemical and Biophysical Research Communications. 284. 443-449 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maeda S, et al.: "Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells"Journal of Biological Chemistry. 276. 44856-44864 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshida H, Hirota K et al.: "Determination of the optimal cut-off value for [13C] urea breath test based on a Helicobacter pylori-specific PCR assay"Journal of Gastroenterology and Hepatology. 15. 155-160 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maeda S, Yoshida H et al.: "Detection of clarithromycin-resistant Helicobacter pylori strains with a preferential homo-duplex formation assay"Journal of Clinical Microbiology. 38. 210-214 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Naeda S, Yoshida H et al.: "Assessment of gastric Carcinoma risk associated with Helicobacter pylori may very depending on the antigen used-CagA specific"Cancer. 88. 1530-1535 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] ogura U, Yoshida H et al.: "Clarithromychin-based triple therapy for non-resistant Helicobacter pylori infection : How long Should it be given ?"Scandinavian Journal of Gastroenterology. 36. 584-588 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] ikenoue T, Maeda S et al.: "Determination of Helicobacter pylori virulence by Simple gene analysis of the cag pathogenicity island"Clinical and Diagnostic Laboratory Immunology. 8. 181-186 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamaji Y, Mitsushima T, et al.: "Inverse background of Helicobacter pylori antibody and pepsinogen in reflux esophagitis compared to gastric Cancer-analysis of 5732 Japanese subjects"Gut. 49. 335-340 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Akanuma M, Maeda S, et al.: "The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease asing short-term Mongolian gerbil infection model"Journal of infectious Disease. 185. 341-347 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshida H, Hirota K, Ogura K, Maeda S, Shiratori Y, Sasaki Y, Omata M: "Determination of the optimal cut-off value for [13C] urea breath test based on a Helicobacter pylori-specific PCR assay"Journal of Gastroenterology an Hepatology. 15. 155-160 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeda S, Yoshida H, Matsunaga H, Ogura K, Kawamata O, Shiratori Y, Omata M: "Detection of clarithromycin-resistant Helicobacter pylori strains with a preferential homo-duplex formation assay"Journal of Clinical Microbiology. 38. 210-214 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, Tagawa H, Kawaguchi R, Mori K, Mafune K, Kawabe T, Shiratori Y, Omata M: "Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used -CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs"Cancer. 88. 1530-1535 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji Y, Akanuma M, Shiratori Y, Omata M: "H. pylori activates NF-kappa B through a signaling pathway involving I kappa B kinases, NF-kappa B- inducing kinase, TRAF2, and TRAF6 in gastric cancer cells"Gastroenterology. 119. 97-108 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, Kyutoku T, Yoshida H, Shiratori Y, Omata M: "Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil"Journal of Experimental Medicine. 192. 1601-1610 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ogura K, Yoshida H, Maeda S, Yamaji Y, kawabe T, Okamoto M, Shiratori Y, Omata M: "Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection : How long should it be given?"Scandinavian Journal of Gastroenterology. 36. 584-588 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshida H, Shiratori Y, Omata M: "Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island"Clinical and Diagnostic Laboratory Immunology. 8. 181-186 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mitsuno Y, Yoshida H, Maeda S, Ogura K, Hirata Y, Kawabe T, Shiratori Y, Omata M: "Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signaling pathway in gastric cancer cells"Gut. 49. 18-22 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeda S, Otsuka M, Hirata Y, Mitsuno Y, Yoshida H, Shiratori Y, Masuho Y, Muramatsu M, Seki N, Omata M: "cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells"Biochemical and Biophysical Research Communication. 284. 443-449 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M: "Inverse background of Helicobacter pylori antibody and pepsinogen in reflux esophagitis compared to gastric cancer -analysis of 5732 Japanese subjects"Gut. 49. 335-340 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hirata Y, Maeda S, Mitsuno Y, Akanuma M, Yamaji Y, Ogura K, Yoshida H, Shiratori Y, Omata H: "Helicobacter pylori activates the cyclin D1 gene through miltogen-activated kinase pathway in gastric cancer cells"Infection and Immunity. 69. 3965-3971 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeda S, Akanuma M, Mitsuno Y, Hirata Y, Ogura K, Yoshida H, Shiratori Y, Omata M: "Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells"Journal of Biological Chemistry. 276. 44856-44864 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akanuma M, Maeda S, Ogura K, Mitsuno Y, Hirata Y, Ikenoue T, Otsuka M, Watanabe T, Yamaji Y, Yoshida H, Kawabe T, Shiratori Y, Omata M: "The uvalutionof putative virulence factors of Helicobacter pylori for gastroduodenal disease using short-term Mongolian gerbil infection model"Journal of Infectious Disease. 185. 341-347 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi